Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis

Abatacept is a cost effective alternative to adalimumab in patients with RA with high ACPA levels.